MyFibroScan

Veröffentlicht von: ECHOSENS

Beschreibung

FibroScan® is the non-invasive solution for comprehensive management of liver health.
Fibroscan® provides unique and patented biomarkers, LSM by VCTE™ (Liver Stiffness Measurement) and CAP™ (Controlled Attenuation Parameter) that benefit from a worldwide clinical evidence with over 2500 peer-reviewed publications and 60+ international guidelines.
myFibroScan app is your everyday FibroScan® companion to access Interpretation Guide and FibroScan® based scores in an easy, fast and intuitive way :
The Interpretation Guide utilizes data from clinical studies to assist providers in interpreting Fibroscan® examination results.
Scores enhance Fibroscan® liver disease assessment with biological markers.
Scores are presented as educational services intended for licensed healthcare professionals. While the scores are about specific medical and healthcare issues, they are not a substitute for/or replacement of personalized medical advice and are not intended to be used as the sole basis for making individualized medical or health-related decisions.
- Agile™3+ is an aid to identify NAFLD patients with advanced fibrosis by combining VCTE™ and routine clinical parameters to reduce the need for liver biopsy. High clinical performances are demonstrated in large external validation cohorts from different geographical origins.
- Agile™4 is an aid to early identify NAFLD patients with cirrhosis by combining VCTE™ and routine clinical parameters. It can help the physicians to manage the disease to prevent liver-related complications such as hepatocellular carcinoma. High clinical performances are demonstrated in large external validation cohorts from different geographical origin.
- Fast™ is an aid to identify at risk NASH patients defined as NASH + NAS≥4 + F≥2. Good to excellent performance in cohorts from different clinical settings (NAFLD tertiary care unit, screening, bariatric surgery) and geographical origins (USA, Europe, Asia). Several publications advocate the use of Fast™.
Ausblenden Mehr anzeigen...

Screenshots

MyFibroScan Häufige Fragen

  • Ist MyFibroScan kostenlos?

    Ja, MyFibroScan ist komplett kostenlos und enthält keine In-App-Käufe oder Abonnements.

  • Ist MyFibroScan seriös?

    Nicht genügend Bewertungen, um eine zuverlässige Einschätzung vorzunehmen. Die App benötigt mehr Nutzerfeedback.

    Danke für die Stimme

  • Wie viel kostet MyFibroScan?

    MyFibroScan ist kostenlos.

  • Wie hoch ist der Umsatz von MyFibroScan?

    Um geschätzte Einnahmen der MyFibroScan-App und weitere AppStore-Einblicke zu erhalten, können Sie sich bei der AppTail Mobile Analytics Platform anmelden.

Benutzerbewertung

5 von 5

2 Bewertungen in Brasilien

5 star
2
4 star
0
3 star
0
2 star
0
1 star
0
Bewertungsverlauf

MyFibroScan Bewertungen

Buggy / Account won’t validate

Nickname 20,000 on

Vereinigte Staaten

App is buggy and unable to send me an email to validate my account so I can use it. It will however successfully send an message for password reset so the issue is not an incorrect email address. I’ve wasted over an hour on trying to get it to work.

Store-Rankings

Ranking-Verlauf
App-Ranking-Verlauf noch nicht verfügbar
Kategorien-Rankings
Diagramm
Kategorie
Rang
Top Kostenlos
251
Top Kostenlos
348
Top Kostenlos
430
Top Kostenlos
490

MyFibroScan Konkurrenten

Name
ECCO IBD
The App for the IBD Community
LIVER-NOTE.Edu
N/V
COVID-19 iChart
COVID-19 drug interactions
PubMed PMC Bookshelf Search
Medical Journals & Articles
Zemedy: IBS & Gut Health Care
Manage IBS & Digestive health
ClinicalKey
ESC CVD Risk Calculation
For healthcare professionals
ONCOassist
The go-to app in oncology
GI Guidelines
GHAPP ACE

MyFibroScan Installationen

Letzte 30 Tage

MyFibroScan Umsatz

Letzte 30 Tage

MyFibroScan Einnahmen und Downloads

Gewinnen Sie wertvolle Einblicke in die Leistung von MyFibroScan mit unserer Analytik.
Melden Sie sich jetzt an, um Zugriff auf Downloads, Einnahmen und mehr zu erhalten.
This page includes copyrighted content from third parties, shared solely for commentary and research in accordance with fair use under applicable copyright laws. All trademarks, including product, service, and company names or logos, remain the property of their respective owners. Their use here falls under nominative fair use as outlined by trademark laws and does not suggest any affiliation with or endorsement by the trademark holders.